M – Pharmaceutical Inc. (the “Company”) is a biopharmaceutical company, headquartered in Vancouver, BC, that trades under the symbol MQ on the Canadian Securities Exchange. The Company is seeking to operate as a medical device company in the market for self-monitoring of blood glucose, focusing on the design, development and commercialization of a minimallyinvasive glucose monitoring product. The SMBG Mosquito is being developed as a less invasive way for persons with diabetes to take blood samples for glucose level checks.